BRPI0818288A2 - Proteínas conjugadas e peptídeos. - Google Patents
Proteínas conjugadas e peptídeos.Info
- Publication number
- BRPI0818288A2 BRPI0818288A2 BRPI0818288A BRPI0818288A2 BR PI0818288 A2 BRPI0818288 A2 BR PI0818288A2 BR PI0818288 A BRPI0818288 A BR PI0818288A BR PI0818288 A2 BRPI0818288 A2 BR PI0818288A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- conjugated proteins
- conjugated
- proteins
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07253992 | 2007-10-09 | ||
| GB0813339A GB0813339D0 (en) | 2008-07-21 | 2008-07-21 | Novel reagents and method for conjugating biological molecules |
| PCT/GB2008/003409 WO2009047500A1 (en) | 2007-10-09 | 2008-10-08 | Novel conjugated proteins and peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0818288A2 true BRPI0818288A2 (pt) | 2015-04-14 |
Family
ID=40225449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0818288 BRPI0818288A2 (pt) | 2007-10-09 | 2008-10-08 | Proteínas conjugadas e peptídeos. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100239517A1 (https=) |
| EP (1) | EP2209494B1 (https=) |
| JP (2) | JP5933923B2 (https=) |
| KR (1) | KR20100090684A (https=) |
| CN (1) | CN101820920B (https=) |
| BR (1) | BRPI0818288A2 (https=) |
| DK (1) | DK2209494T3 (https=) |
| ES (1) | ES2597849T3 (https=) |
| WO (1) | WO2009047500A1 (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0316294D0 (en) * | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
| CA2670618C (en) | 2006-12-15 | 2016-10-04 | Baxter International Inc. | Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life |
| EP2374481B1 (en) | 2008-07-21 | 2015-11-04 | Polytherics Limited | Novel reagents and method for conjugating biological molecules |
| WO2010033216A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of nesiritide peptides |
| EP2341942A1 (en) | 2008-09-19 | 2011-07-13 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
| GB0912485D0 (en) | 2009-07-17 | 2009-08-26 | Polytherics Ltd | Improved conjugation method |
| US9005598B2 (en) | 2009-03-04 | 2015-04-14 | Polytherics Limited | Conjugated proteins and peptides |
| GB0922354D0 (en) | 2009-12-21 | 2010-02-03 | Polytherics Ltd | Novel polymer conjugates |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| KR101912335B1 (ko) | 2009-07-27 | 2018-10-26 | 리폭센 테크놀로지즈 리미티드 | 비혈액 응고 단백질의 글리코폴리시알화 |
| CN102497884A (zh) | 2009-07-27 | 2012-06-13 | 巴克斯特国际公司 | 凝血蛋白缀合物 |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| CN106110311A (zh) | 2009-07-27 | 2016-11-16 | 百深公司 | 凝血蛋白缀合物 |
| EP2495258B1 (en) * | 2009-10-29 | 2016-12-07 | Korea Advanced Institute Of Science And Technology | Catechol polyethylene glycol derivative and protein or peptide conjugates, and method for preparing same |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| HUE049352T2 (hu) | 2010-12-22 | 2020-09-28 | Baxalta GmbH | Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására |
| JP6202707B2 (ja) * | 2011-10-13 | 2017-09-27 | 国立大学法人鳥取大学 | 新規細胞膜透過ペプチド |
| MY190257A (en) | 2012-04-16 | 2022-04-11 | Cantab Biopharmaceuticals Patents Ltd | Optimised subcutaneous therapeutic agents |
| US9650331B2 (en) | 2012-06-18 | 2017-05-16 | Polytherics Limited | Conjugation reagents |
| GB201210770D0 (en) | 2012-06-18 | 2012-08-01 | Polytherics Ltd | Novel conjugation reagents |
| US9441010B2 (en) * | 2012-08-08 | 2016-09-13 | Clarkson University | Method for selective derivatization of oligohistidine sequence of recombinant proteins |
| ES2885854T3 (es) | 2014-10-14 | 2021-12-15 | Polytherics Ltd | Proceso para la conjugación de un péptido o proteína con un reactivo que comprende un grupo saliente que incluye una porción de PEG |
| US10098960B2 (en) | 2015-04-03 | 2018-10-16 | Ucl Business Plc | Polymer conjugate |
| WO2017122019A1 (en) | 2016-01-12 | 2017-07-20 | Crescendo Biologics Limited | Immunoconjugates that bind prostate specific membrane antigen (psma) |
| WO2017161206A1 (en) | 2016-03-16 | 2017-09-21 | Halozyme, Inc. | Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use |
| CN109152845B (zh) | 2016-04-14 | 2022-07-12 | 宝力泰锐克斯有限公司 | 含有在环内包含至少两个(-ch2-ch2-o-)单元的接头的缀合物和缀合试剂 |
| GB201608936D0 (en) | 2016-05-20 | 2016-07-06 | Polytherics Ltd | Novel conjugates and novel conjugating reagents |
| WO2017212250A1 (en) | 2016-06-06 | 2017-12-14 | Polytherics Limited | Antibodies, uses thereof and conjugates thereof |
| GB201614162D0 (en) | 2016-08-18 | 2016-10-05 | Polytherics Ltd | Antibodies, uses thereof and conjugates thereof |
| DE102017103050B4 (de) * | 2017-02-15 | 2019-05-16 | Hoerbiger Automatisierungstechnik Holding Gmbh | Fahrwerk einer transportablen Einrichtung |
| GB201711068D0 (en) | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| US20220411463A1 (en) * | 2019-03-18 | 2022-12-29 | Khashayar Karimian | Mate and separate: a convenient and general method for the separation and purification of target molecules from biological media by phase transition of pegylated recognition agents. |
| WO2022266498A1 (en) * | 2021-06-17 | 2022-12-22 | Nektar Therapeutics | Histidine-selective polymer reagents |
| AU2023228374A1 (en) | 2022-03-03 | 2024-09-19 | Cambridge Enterprise Limited | Therapeutic antibodies |
| EP4556907B1 (en) * | 2023-11-20 | 2026-02-04 | Miltenyi Biotec B.V. & Co. KG | Site-specific conjugation of single domain antibody fragments (vhh) using equilibrium transfer alkylation reagent (etac) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340522C (en) * | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| US6552170B1 (en) * | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| CA2293777A1 (en) * | 1997-06-25 | 1999-01-07 | Innogenetics N.V. | Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag |
| US5985263A (en) * | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
| FR2778918B1 (fr) * | 1998-05-25 | 2000-07-21 | Commissariat Energie Atomique | Baton moleculaire et ses applications |
| DK1656952T3 (da) * | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| GB0316294D0 (en) * | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
-
2008
- 2008-10-08 KR KR1020107010204A patent/KR20100090684A/ko not_active Ceased
- 2008-10-08 ES ES08806549.5T patent/ES2597849T3/es active Active
- 2008-10-08 DK DK08806549.5T patent/DK2209494T3/en active
- 2008-10-08 JP JP2010528477A patent/JP5933923B2/ja not_active Expired - Fee Related
- 2008-10-08 EP EP08806549.5A patent/EP2209494B1/en not_active Not-in-force
- 2008-10-08 US US12/682,057 patent/US20100239517A1/en not_active Abandoned
- 2008-10-08 WO PCT/GB2008/003409 patent/WO2009047500A1/en not_active Ceased
- 2008-10-08 CN CN200880110579.XA patent/CN101820920B/zh not_active Expired - Fee Related
- 2008-10-08 BR BRPI0818288 patent/BRPI0818288A2/pt not_active Application Discontinuation
-
2016
- 2016-03-02 JP JP2016040039A patent/JP6250083B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100239517A1 (en) | 2010-09-23 |
| JP2010540677A (ja) | 2010-12-24 |
| JP6250083B2 (ja) | 2017-12-20 |
| CN101820920B (zh) | 2014-08-06 |
| CN101820920A (zh) | 2010-09-01 |
| EP2209494B1 (en) | 2016-07-20 |
| JP5933923B2 (ja) | 2016-06-22 |
| ES2597849T3 (es) | 2017-01-23 |
| EP2209494A1 (en) | 2010-07-28 |
| JP2016172720A (ja) | 2016-09-29 |
| KR20100090684A (ko) | 2010-08-16 |
| WO2009047500A1 (en) | 2009-04-16 |
| DK2209494T3 (en) | 2016-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0818288A2 (pt) | Proteínas conjugadas e peptídeos. | |
| DK3118220T3 (da) | Protein | |
| DK2046826T3 (da) | Exendin-fusionsproteiner | |
| DK2061886T3 (da) | Små kationiske immunomodulerende peptider | |
| EP2215246A4 (en) | PROTEIN SCAFFOLDS | |
| EP2093287A4 (en) | PEPTIDE BINDER IGG | |
| ATE451392T1 (de) | Gegen amyloid-beta peptid gerichtete antikörper | |
| DK2035447T3 (da) | Polypeptid | |
| EP2118122A4 (en) | NOVEL ANTIMICROBIAL PEPTIDES | |
| HUE038501T2 (hu) | Antitest készítmények | |
| PL2465864T3 (pl) | Szczepionki z peptydem pochodzącym z Eph4 | |
| BRPI0814971A2 (pt) | Proteína | |
| EP2172198A4 (en) | P27 PROTEIN INDUKTOR | |
| EP2139525A4 (en) | FUSION PROTEIN FOR REMOVAL OF AMYLOID BETA PEPTIDE | |
| BRPI0915367A2 (pt) | peptídeos e epítopos anti-p2x7 | |
| BRPI0814127A2 (pt) | Polipeptídeos imunegênicos e anticorpos monoclonais | |
| EP2010561A4 (en) | ANTIMICROBIAL PEPTIDES | |
| EP2300033A4 (en) | CONJUGATES OF COLLAGEN PEPTIDE AND USES THEREOF | |
| EP1912680A4 (en) | HER-2 PEPTIDE | |
| EP1858914A4 (en) | NETWORKS OF PEPTIDES | |
| EP2101804A4 (en) | PROANGIOGENIC PEPTIDES | |
| DE602006003063D1 (de) | Tripeptid- und tetrapeptidsulfone | |
| DK1809660T3 (da) | Thymus-specifikt protein | |
| ATE530564T1 (de) | Peptid-komplement-konjugate | |
| DK2021364T3 (da) | Forbedrede antimikrobielle peptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 47/64 (2017.01), A61K 47/60 (2017.01), A61K 4 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |